Product Details:
Payment & Shipping Terms:
|
Name: | Velpatasvir | CAS: | 1377049-84-7 |
---|---|---|---|
Molecular Formula: | C49H54N8O8 | ||
High Light: | 668270 12 0,1377049 84 7 |
Velpatasvir CAS : 1377049-84-7 GMP DMF
Name : Velpatasvir
Chemical Name : Methyl { ( 2S ) - 1 - [ ( 2S , 5S ) - 2 - ( 9 - { 2 - [ ( 2S , 4S ) - 1 - { ( 2R ) - 2 - [ ( methoxycarbonyl ) amino ] - 2 - phenylacetyl } - 4 - ( methoxymethyl ) - 2 - pyrrolidinyl ] - 1H - imidazol - 4 - yl } - 1 , 11 - dihydroisochromeno [4' , 3' : 6 , 7 ] naphtho [ 1 , 2-d ] imidazol - 2 - yl ) - 5 - methyl - 1 - pyrrolidinyl ] - 3 - methyl - 1 - oxo - 2 - butanyl } carbamate
Molecular Formula : C49H54N8O8
Molecular Weight : 883.02
Description :
Velpatasvir is innovated by Gilead to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients. Velpatasvir is a Direct-Acting Antiviral (DAA) medication used together with Sofosbuvir. The mechanism of action is as a Breast Cancer Resistance Protein Inhibitor, and P-Glycoprotein Inhibitor, and Organic Anion Transporting Polypeptide 1B1 Inhibitor, and Organic Anion Transporting Polypeptide 1B3 Inhibitor, and Organic Anion Transporting Polypeptide 2B1 Inhibitor. It blocks NS5A, a protein necessary for hepatitis C virus replication assembly.
The drug might be protected by patents in some courtires or areas. We only sell it to non patent protected countries or areas. The sale to patent protection countries and areas is only for R & D purpose. The buyers should take all responsiblity of patent status in his countries or areas.
Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.